(Q45250947)

11 December 2017

title

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes (English)

1 reference

11 December 2017

0 references

1 reference

V Fonseca

1

1 reference

11 December 2017

A Schweizer

2

1 reference

11 December 2017

D Albrecht

3

1 reference

11 December 2017

M A Baron

4

1 reference

11 December 2017

I Chang

5

1 reference

11 December 2017

S Dejager

6

1 reference

11 December 2017

publication date

27 March 2007

1 reference

11 December 2017

1 reference

11 December 2017

volume

50

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

1148-1155

1 reference

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

11 December 2017

cites work

1 reference

12 December 2020

Combination of insulin and metformin in the treatment of type 2 diabetes

1 reference

12 December 2020

Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin

1 reference

12 December 2020

Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year

1 reference

12 December 2020

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

12 December 2020

Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance

1 reference

12 December 2020

Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.

1 reference

12 December 2020

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

1 reference

12 December 2020

Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia

1 reference

12 December 2020

1 reference

12 December 2020

Combination therapies with insulin in type 2 diabetes

1 reference

12 December 2020

Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes

1 reference

12 December 2020

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response

1 reference

12 December 2020

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

1 reference

12 December 2020

Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification.

1 reference

12 December 2020

10.1007/S00125-007-0633-0

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1022829086

0 references

1 reference